Stephens Consulting, LLC Pfizer Inc Transaction History

Stephens Consulting, LLC

$422 Billion
Q2 2025

A detailed history of Stephens Consulting, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Stephens Consulting, LLC holds 2,210 shares of PFE stock, worth $52,885. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,210

Previous 2,454 9.94%

Holding current value

$52,885

Previous $62.2 Million 13.85%

% of portfolio

0.01%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 25, 2025	SELL	$21.59 - $24.84 $5,267 - $6,060	-244 Reduced 9.94%	2,210 $53.6 Million
Q1 2025 Apr 17, 2025	SELL	$25.01 - $27.13 $84,333 - $91,482	-3,372 Reduced 57.88%	2,454 $62.2 Million
Q4 2024 Jan 24, 2025	BUY	$24.8 - $30.19 $57,486 - $69,980	2,318 Added 66.08%	5,826 $155 Million
Q3 2024 Oct 18, 2024	SELL	$27.7 - $31.39 $11,218 - $12,712	-405 Reduced 10.35%	3,508 $102 Million
Q2 2024 Jul 29, 2024	BUY	$25.26 - $29.6 $6,542 - $7,666	259 Added 7.09%	3,913 $109 Million
Q1 2024 Apr 17, 2024	SELL	$25.89 - $29.73 $30,834 - $35,408	-1,191 Reduced 24.58%	3,654 $101 Million
Q4 2023 Feb 01, 2024	BUY	$26.13 - $33.94 $26,130 - $33,940	1,000 Added 26.01%	4,845 $139 Million
Q3 2023 Oct 25, 2023	BUY	$32.09 - $37.51 $16,847 - $19,692	525 Added 15.81%	3,845 $128 Million
Q2 2023 Jul 20, 2023	SELL	$36.12 - $41.79 $2,709 - $3,134	-75 Reduced 2.21%	3,320 $122 Million
Q1 2023 Apr 19, 2023	SELL	$39.39 - $51.28 $157 - $205	-4 Reduced 0.12%	3,395 $139 Million
Q3 2022 Jan 19, 2023	BUY	$43.76 - $53.42 $10,852 - $13,248	248 Added 7.87%	3,399 $149 Million
Q2 2022 Jan 19, 2023	SELL	$46.53 - $55.17 $49,787 - $59,031	-1,070 Reduced 25.35%	3,151 $165 Million
Q1 2022 Jan 19, 2023	SELL	$45.75 - $56.69 $40,260 - $49,887	-880 Reduced 17.25%	4,221 $219 Million
Q4 2021 Jan 19, 2023	BUY	$41.32 - $61.25 $210,773 - $312,436	5,101 New	5,101 $301 Million

Others Institutions Holding PFE

# of Institutions

3,347

Shares Held

3.61B

Call Options Held

104M

Put Options Held

129M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $134B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Consulting, LLC with notifications on news.

Account

Stephens Consulting, LLC Pfizer Inc Transaction History